Siteman Cancer Center received an “exceptional” rating from the NCI for its research
On Jul. 7, 2015, the National Cancer Institute (NCI) awarded the Siteman Cancer Center at Barnes-Jewish Hospital and…
OHSU sets fundraising record by meeting $1 billion challenge from Nike co-founder and wife
On Jun. 24, 2015, Oregon Health and Science University (OHSU) announced it had met Nike co-founder Phil Knight…
Sylvester Comprehensive Cancer Center was designated a Cancer Center of Excellence by the State of Florida
On Mar. 25, 2015, the Sylvester Comprehensive Cancer Center was designated a Cancer Center of Excellence by the…
Dendreon was acquired by Valeant Pharmaceuticals for $495 million
On Feb. 23, 2015, a bankruptcy judge approved the sale of the assets of Dendreon Corp., a Seattle-based…
Yale Cancer Center was awarded a SPORE grant for translational research in lung cancer
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
The Fred & Pamela Buffett Cancer Center announced recruitment of five leading cancer researchers
On Dec. 3, 2014, the Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center…
Ford Family Foundation awarded $5 million grant to advance the OHSU Knight Cancer Institute’s rural outreach
On Nov. 5, 2014, the Ford Family Foundation announced a $5 million grant to the Knight Cancer Institute…
Mary-Claire King received Lasker Foundation Award
On Sept. 8, 2014, the University of Washington and UW Medicine announced that Mary-Claire King, UW professor of…
University of Missouri School of Medicine received $2.4 million gift to funds endowed faculty chair in oncology
On Aug. 21, 2014, Mark McAndrew, a resident of McKinney, Texas, gave $2.4 million to the University of…
Biotechnology | Chemical | FDA | Oncology | Therapeutics | Women's Health
FDA approved Genentech’s Avastin plus chemotherapy for treatment of advanced cervical cancer
On Aug. 14. 2014, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Avastin (bevacizumab)…
OHSU Knight Cancer Challenge announced $100 million gift
On Jul. 28, 2014, OHSU announced it has received a $100 million gift from an unnamed donor who…
Genentech announced a definitive agreement to acquire Seragon Pharmaceuticals
On Jul. 1, 2014, Genentech entered into an agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company…
Case Western Reserve University announced major philanthropic pledges
On Jun. 30, 2014, leaders from Case Western Reserve University and University Hospitals announced that Char and Chuck…
OHSU Collaborative Life Sciences Building launched new era in health and science research and education
On Jun. 26, 2014, a $300 million building opened in Portland is shared by Portland State University and Oregon…
Bezos family donated $20 million to the Fred Hutch to develop therapies that ‘melt’ cancer
On Apr. 7, 2014, the Fred Hutchinson Cancer Research Center announced that the Bezos family had committed $20…
Laura and Isaac Perlmutter donated $50 million to advance cancer research and treatment at NYU Langone Medical Center
On Jan. 29, 2014, NYU Langone Medical Center announced it had received an initial gift in excess of…
Siteman Cancer Center debuted the first single-vault proton therapy center in the country
On Dec. 19, 2013, the Siteman Cancer Center debuted the first single-vault proton therapy center in the U.S.:…
Biotechnology | FDA | Oncology | Therapeutics
Genentech drug Gazyva (obinutuzumab) was approved
On Nov. 13, 2013, Genentech announced that it’s drug Gazyva (obinutuzumab) was approved by the U.S. Food and…
Karmanos Cancer Institute joined McLaren Health Care
On Oct. 30, 2013, the Karmanos Cancer Institute and McLaren Health Care signed an agreement that created the…
Nike co-founder Phil Knight and wife Penny issued $1 billion cancer challenge
On Sept. 21, 2013, philanthropists Phil and Penny Knight pledged $500 million to kick-start a $1 billion cancer…
The Markey Cancer Center became an NCI-designated Cancer Center
On Jul. 12, 2013. the University of Kentucky Markey Cancer Center (MCC) was joined by national, state and…
UNMC named new cancer center the Fred & Pamela Buffett Cancer Center
On Jun. 7, 2013, the University of Nebraska Board of Regents approved renaming the UNMC Eppley Cancer Center…
World Ovarian Cancer Day was established
On May 8, 2013, was the first World Ovarian Cancer Day. On this day, ovarian cancer organizations from…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
Genentech drug Kadcyla (ado-trastuzumab emtansine) was approved
On Feb. 22, 2013, the U.S. Food and Drug Administration (FDA) announced they had approved Genentech’s licensed ado-trastuzumab…
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
The University of Kansas Cancer Center earned National Cancer Institute designation
On Jul. 12, 2012 the University of Kansas Cancer Center earned National Cancer Institute designation. Through efforts initially…
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
Treatment outcomes in black and white children with cancer was published
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
Biotechnology | CDC | Oncology | Therapeutics
Report to the nation finds continuing declines in cancer death rates since the early 1990s
On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…
Single antibody shrinks variety of human tumors transplanted into mice, study showed
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…